(Q46735466)

24 December 2017

title

Early effects of olanzapine on serum levels of ghrelin, adiponectin and leptin in patients with schizophrenia (English)

1 reference

24 December 2017

0 references

0 references

Hideki Hosojima

1

1 reference

24 December 2017

Takashi Togo

2

1 reference

24 December 2017

Toshinari Odawara

3

1 reference

24 December 2017

Koichi Hasegawa

4

1 reference

24 December 2017

Satoshi Miura

5

1 reference

24 December 2017

Yuiko Kato

6

1 reference

24 December 2017

Akiko Kanai

7

1 reference

24 December 2017

Akihiko Kase

8

1 reference

24 December 2017

Hirotake Uchikado

9

1 reference

24 December 2017

Yoshio Hirayasu

10

1 reference

24 December 2017

language of work or name

English

0 references

publication date

4 October 2005

1 reference

24 December 2017

Journal of Psychopharmacology

published in

1 reference

24 December 2017

volume

20

1 reference

24 December 2017

issue

1

1 reference

24 December 2017

page(s)

75-79

1 reference

24 December 2017

Serum leptin levels increase rapidly after initiation of clozapine therapy

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056647

A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056647

Effect of olanzapine on body composition and energy expenditure in adults with first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056647

Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056647

Effects of long-term treatment with antipsychotics on serum leptin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056647

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056647

cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056647

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056647

Structure-activity relationship of ghrelin: pharmacological study of ghrelin peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056647

Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056647

Relationship between levels of insulin or triglycerides and serum concentrations of the atypical antipsychotics clozapine and olanzapine in patients on treatment with therapeutic doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056647

Olanzapine increases plasma ghrelin level in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056647

A role for ghrelin in the central regulation of feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056647

Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056647

Adiponectin acts in the brain to decrease body weight.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056647

A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056647

Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056647

Evaluation of insulin sensitivity in healthy volunteers treated with olanzapine, risperidone, or placebo: a prospective, randomized study using the two-step hyperinsulinemic, euglycemic clamp

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056647

Serum ghrelin concentrations in patients receiving olanzapine or risperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056647

Serum adiponectin concentrations during treatment with olanzapine or risperidone: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056647

Ghrelin induces adiposity in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056647

Post-prandial decrease of circulating human ghrelin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056647

Bodyweight gain with atypical antipsychotics. A comparative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056647

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056647

Minireview: From anorexia to obesity--the yin and yang of body weight control

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056647

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056647

21 January 2018

Identifiers

DOI

10.1177/0269881105056647

1 reference

24 December 2017

1 reference

24 December 2017